Orexigen Wins Backing for New Diet Pill, Shares Soar

Orexigen Wins Backing for New Diet Pill, Shares Soar
Orexigen Therapeutics Inc. won a U.S. panel’s backing for Contrave, a new diet pill that may be the first prescription weight-loss drug approved in more than a decade. The company’s shares almost tripled in extended trading.
Read more on BusinessWeek

STUDY: Alcohol consumption has an impact on final grades
Final exams are less than a week away, and students will be confronted with choices that will have an impact on their academic performance. A recent study conducted at the U.S. Air Force Academy found that alcohol consumption before and during final exam period is detrimental to students’ performance. According to the National Institute on Alcohol Abuse and Alcoholism, about 25 percent of …
Read more on The Vanderbilt Hustler

Teens say ‘no’ to underage drinking
A group of Redlands teens are taking a stance against underage drinking and plan to ask the City Council follow their lead.
Read more on Redlands Daily Facts